Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
713 (USA) · Dr. Kowalski
consented 2013-05-31
AEs
4
Serious
0
Dropout signal
–
Adverse events
moderate
assessed
Moderate BACK PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-30 (study day 31.0); relationship: REMOTE
moderate
assessed
Moderate DELIRIUM — outcome: RECOVERED/RESOLVED; onset 2013-07-01 (study day 32.0); relationship: POSSIBLE; serious criteria: hospitalization
mild
assessed
Mild RASH PRURITIC — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-21 (study day 22.0); relationship: PROBABLE
mild
assessed
Mild RASH PRURITIC — outcome: RECOVERED/RESOLVED; onset 2013-06-21 (study day 22.0); relationship: PROBABLE
Data queries
No data queries.